Homeopathic drug discovery: Theory update and methodological aspect

Expert Opinion on Drug Discovery

Volumn 3, Issue 8, 2008, Pages 979-990

  Khuda Bukhsh, Anisur Rahman ^a   Pathak, Surajit ^a  

^a UNIVERSITY OF KALYANI   (India)

Author keywords

Avogadro's limit; Discovery; Homeopathy; Physical concept; Potentization; Similia principle; Ultra high dilution; Water structure

Indexed keywords

3,5 DICHLOROPHENOL; ACETYLSALICYLIC ACID; ALCOHOL; ANTINEOPLASTIC AGENT; BEE VENOM; HISTAMINE; HOMEOPATHIC AGENT; PLACEBO; RUTA 6C;

ALLERGY; ANTIBACTERIAL ACTIVITY; CLINICAL TRIAL; CONCENTRATION (PARAMETERS); DISEASE EXACERBATION; DRUG ALCOHOL INTERACTION; DRUG EFFICACY; DRUG MECHANISM; DRUG POTENCY; DRUG SAFETY; HOMEOPATHY; HUMAN; NONHUMAN; PRIORITY JOURNAL; REVIEW; SINGLE DRUG DOSE; THROMBOSIS; TRADITIONAL MEDICINE; VIBRIO CHOLERAE;

EID: 48749093228     PISSN: 17460441     EISSN: None     Source Type: Journal    
DOI: 10.1517/17460441.3.8.979     Document Type: Review

References (115)

1. Campbell C. Medicine, rhetoric and undermining: managing credibility in homeopathic practice. Homeopathy 2008;97(2):76-82
2. European Council for Classical Homeopathy. European Guidelines for Homeopathic Education. 2nd edition. 2000. Available from: www.homeopathy-ecch.org/education.html
3. Vallance AK. Can Biological activity be maintained at ultra-high dilution? An overview of homeopathy, evidence, and Bayesian philosophy. J Altern Complement Med 1998;4(1):49-76
4. Dantas F, Fisher P, Walach H, et al. A systematic review of the quality of homeopathic pathogenetic trials published from 1945 to 1995. Homeopathy 2007;96(1):4-16
5. Bellavitte P, Conforti A, Piasere V, et al. Immunology and homeopathy: I historical background. Evid Based Complement Alternat Med 2005;2:441-52
6. HPCUS. Available from: http://www.hpus.com
7. Anagnostatos GS, Pissis P, Viras K, et al. Theory and experiments on high dilutions. In: Ernst E, Hahn EG, editors, Homoeopathy - a critical appraisal, Butterworth-Heinemann, Reed Educational and Professional Publishers Ltd.; 1998. p. 153-66
8. Allegre CJ, Provost A, Jaupart C. Oscillatory zoning: a pathological case of crystal growth. Nature 1989;294:223-28
9. Bellavite P, Signorini A. The emerging science of homeopathy. North Atlantic, Berkeley; 2002
10. Chaplin MF. The memory of water: an overview. Homeopathy 2007;96:143-50
11. Samal S, Geckeler KE. Unexpected solute aggregation in water on dilution. Chem Commun 2001;2224-25
12. Anick DJ. Stable zwitterionic water complexes: the active ingredient in homeopathy? Presented in part at the 4th scientific symposium of the homeopathic research network, Washington, DC, November 1998; Also in the fall issue of Journal of the American Institute of Homeopathy (JAIH). 1999:14-5
13. Jongma RT, Huang Y, Shi S, et al. Rapid evaporative cooling is a way to suppress fragmentation in mass spectrometry: synthesis of unprotonated water clusters. J Phy Chem 1998;102:8847-54
14. Anick DJ. The octave potencies convention: a mathematical model of dilution and succussion. Homeopathy 2007;96:202-8
15. Davydov AS. Energy and electron transport in biological systems. In: Ho MW, Popp FA, Warnke U, editors, Bioelectrodynamics and biocommunication. World Scientific: London; 1994. p. 411-30
16. Tschulakow AV, Yan Y, Klimek W. A new approach to the memory of water. Homeopathy 2005;94:241-7
17. Elia V, Napoli E, Germano R. The "Memory of Water": an almost deciphered enigma. Dissipative structures in extremely dilute aqueous solutions. Homeopathy 2007;96:163-9
18. Davenas E, Beauvais F, Amara J, et al. Human basophil degranulation triggered by very dilute antiserum against IgE. Nature 1988;333:816-8
19. Hirst SJ, Hayes NA, Burridge J, et al. Human basophil degranulation is not triggered by very dilute antiserum against human IgE. Nature 1993;366(6455):525-7
20. Belon P, Cumps J, Ennis M, et al. Inhibition of human basophil degranulation by successive histamine dilutions: results of an European multi-centre trial. Inflamm Res 1999;48(1):17-8
21. Belon P, Cumps J, Ennis M, et al. Histamine dilutions modulate basophil activation. Inflamm Res 2004;53(5)181-8
22. Lo SY. Anomalous state of Ice. Mod Phys Lett B 1996;10(19):909-19
23. Weingartner O. NMR-features that relate to homeopathic sulphur potencies. Berlin J Res Hom 1990;1:61-8
24. Sukul N, Ghosh S, Sukul A, et al. Variation in fourier transform infrared spectra of some homeopathic potencies and their dilution media. J Altern Complement Med 2005;11(5):807-12
25. Andersson PU, Tomsic A, Andersson MB, et al. Emission of small fragments during water cluster collisions with graphite surface. Chem Phys Lett 1997;279:100-06
26. Markovic N, Andersson PU, Nagard MB, et al. Scattering of water from graphite: simulations and experiments. Chem Phys 1999;247:413
27. Wisniewski ES, Folmer DE, Castleman AW Jr. Spectroscopic studies of cluster species. Final Program 383, PHYS Fall 2000 Technical Program, 222nd ACS National Meeting; Chicago, ILL; 2001. p. 26-30
28. Yui H. Analysis of hydrogen bonding structure around hydrophobic cores in ethanol water solution using Laser induced excess electron-stimulated Raman Scattering Technique, Pacifi Chem, Honolulu, Hawaii; 2000. p. 14-9
29. Suslick KS. The Chemical effects of ultrasound. Sci Am 1989:80-6
30. Borland, Douglas M. Pneumonias. Pamphlet published by the The British Homoeopathic Association. 1939:76
31. Banerji P. Principle of quick selection of drugs and potencies established by clinical trials. Presented and published in the Proceedings of 40e Congress De La Ligue Medicate Homoeopathique Internationale Lyon - France - 1985
32. Connelly BR. How does homeopathy work? Part-1, Part-2 and Part-3. 2002. Available from: http://home.attbi.com/~brc17
33. Rey L. Thermoluminescence of ultra-high dilutions of lithium chloride and sodium chloride. Phys Acta 2003;323:67-74
34. Rey L. Can low-temperature thermoluminiscence cast light on nature of ultra-high dilutions? Homeopathy 2007;96:170-4
35. Anick DJ, Ives JA. The silica hypothesis for homeopathy: physical chemistry. Homeopathy 2007;96:189-95
36. Khuda-Bukhsh AR. Laboratory research in homeopathy. Integr Cancer Ther 2006;5(4):1-13
37. Khuda-Bukhsh AR. Towards understanding molecular mechanisms of action of homeopathic drugs: an overview. Mol Cell Biochem 2003;253:339-45
38. Matsumoto J. Vanadate, molybdate and tungstate for orthomolecular medicine. Med Hypotheses 1994;43:177-82
39. Matsumoto J. Molecular mechanism of biological responses to homeopathic medicines. Med Hypotheses 1995;45:292-6
40. E Water Clusters. World Scientific: Singapore; 1998
41. Pertsemlidis A, Saxena AM, Soper AK, et al. Direct evidence for modified solvent structure within the hydration shell of a hydrophobic amino acid. Proc Natl Acad Sci 1998;93(20):10769-74
42. Hameroff S. Departments of Anesthesiology and Psychology, Associate Director, Center for Consciousness Studies, The University of Arizona, Tucson, Arizona. 2001. Available from: http://www.consciousness.arizona.edu/hameroff
43. Buehler GA. Are microtubules the 'nerves' of the cell? 2002. Available from: http://www.basic.nwu.edu/g-buehler/contents.htm#cont3
44. Stebbing ARD. Hormesis - the stimulation of growth by low levels of inhibitors. Sci Total Environ 1982;22:213-34
45. Weigant FA, Van Rijn J, Van Wijk R. Enhancement of the stress response by minute amounts of cadmium in sensitized Reuber H35 hepatoma cells. Toxicology 1997;116:27-37
46. Van Wijk R, Weigant FA. Cultured mammalian cells in homoeopathy research: the simila principle of self-recovery. Utrecht, Utrecht University, the Netherlands; 1994:1-30
47. Van Wijk R, Weigant FA. Homoeopathy and the mammalian cell: programmed cell recovery and new therapeutic strategies. In: Ernst E, Hahn EG, editors, Homeopathy - a critical appraisal, Butterworth-Heinemann, Reed Educational and Professional Publishers Ltd. 1998. p. 180-86
48. Calabrese EJ, Baldwin LA, Holland CD. Hormesis: a highly generalizable and reproducible phenomenon with important implications for risk assessment. Risk Anal 1999;19(2):261-81
49. Calabrese EJ. Paradigm lost, paradigm found: the re-emergence of hormesis as a fundamental dose response model in the toxicological sciences. Environ Pollut 2005;138(3):379-11
50. Khuda-Bukhsh AR. Potentized homeopathic drugs act through regulation of gene expression: a hypothesis to explain their mechanism and pathways of action in vivo. Complement Ther Med 1997;5:43-6
51. Mallick P, Chakrabarti Mallick J, Guha B, et al. Ameliorating effect of microdoses of a potentized homeopathic drug, Arsenicum Album, on arsenic-induced toxicity in mice. BMC Complement Altern Med 2003;3(7):1-18
52. The HomBRex database. Available from: http://www.carstens-stiftung.de/ hombrex
53. Van Wijk R. The in vitro evidence for an effect of high homeopathic potencies - A systematic review of the literature. Complement Ther Med 2007;15:139-41
54. Paris A, Gonnet N, Chaussard C, et al. Effect of homeopathy on analgesic intake following knee ligament reconstruction: a phase III monocentre randomized placebo controlled study. Br J Clin Pharmacol 2008;65(2):180-7
55. Shang A, Huwiler-Müntener K, Nartey L, et al. Are the clinical effects of homoeopathy placebo effects? Comparative study of placebo-controlled trials of homoeopathy and allopathy. Lancet 2005;366(9487):726-32
56. Linde K, Jonas WB, Melchart D, et al. The methodological quality of randomized controlled trials of homeopathy, herbal medicines and acupuncture. Int J Epidemiol 2001;30(3):526-31
57. Linde K, Clausius N, Ramirez G, et al. Are the clinical effects of homeopathy placebo effects? A meta-analysis of placebo-controlled trials. Lancet 1997;350(9081):834-43
58. Witt CM, Bluth M, Albrecht H, et al. The in vitro evidence for an effect of high homeopathic potencies - a systematic review of the literature. Complement Ther Med 2007;15:128-38
59. Sibille M, Deigat N, Olagnier V, et al. Adverse events in phase one studies: a study in 430 healthy volunteers. Eur J Clin Pharmacol 1992;42(4):389-93
60. Aguejouf O, Belougne-Malfatti E, Doutremepuich F, et al. Thromboembolic complications several days after a single-dose administration of Aspirin. Thromb Res 1998;89:123-7
61. Aguejouf O, Malfatti E, Belon P, et al. Effects of acetyl salicylic acid therapy on an experimental thrombosis induced by laser beam. Thromb Res 2000;99:595-02
62. Boiron J, Abecassls J, Belon P. The effects of Hahnemannian potencies of 7c Histaminum and 7c Apis Mellifica upon basophil degranulation in allergic patients. Aspects of Res Hom Lyon: Boiron; 1983;61-6
63. Brack A, Strube J, Stolz P, et al. Effects of ultrahigh dilutions of 3,5-dichlorophenol on the luminescence of the bacterium Vibrio fischeri. Biochem Biophy Acta 2003;1621:253-60
64. Sukul NC, Ghosh S, Sinhababu SP. Reduction in the number of infective Trichinella spiralis larvae in mice by use of homeopathic drugs. Forsch Komplementarmed Klass Naturheilkd 2005;12:202-5
65. Sato DV, Wal R, De Oliviera CC, et al. Histopathological and immunotyping studies on normal and sarcinoma 180 - bearing mice treated with a complex homeopathic medication. Homeopathy 2005;94:26-32
66. Pedalino CM, Perazzo FF, Carvalho JC, et al. Effect of Atropa belladonna and Echinacea angustifolia in homeopathic dilution on experimental peritonitis. Homeopathy 2004;93:193-8
67. Jonas WB, Dillner D. Protection of mice from Tularemia infection from ultra-low, serial agitated dilutions prepared from Francisella tularensis infected tissue. J Scient Explor 2000;14:35-52
68. Weisman Z, Oberbaum M, Topper R, et al. High dilutions of antigens modulate the immune response to KLH. In: Bastide M, editor, Signals images. Dordrecht: Kluwer Academic Publisher; 1997. p. 179-89
69. Bentwich Z, Weisman Z, Topper R, et al. Specific immune response to high dilutions of KLH; transfer of immunological information. In: Bornoroni C, editor, Omeomed 92, Bologna, Editrice Compositori; 1993. p. 9-14
70. Bastide M, Doucet-Jaboeuf M, Daurat V. Activity and chronopharmacology of very low doses of physiological immune disorders. Immunol Today 1985;6:234-5
71. Bastide M. Immunological examples on ultra high dilution research. In: Endler PC, Schulte J, editors, Ultra high dilution, Dordrecht: Kluwer Academic Publisher; 1994. p. 27-33
72. Banik S, Khuda Bukhsh AR. Alteration of cytogenetical and hematological effects of ultra-low doses of Ginseng in whole body X-ray irradiated mice. Nucleus 1996;49:28-35
73. Khuda Bukhsh AR, Maity S. Alteration of cytogenetical effects by oral administration of a homeopathic drug, Ruta Graveolens in mice exposed to sub lethal X-ray irradiation. Berlin J Res Home 1990;1:264-74
74. Kundu SN, Mitra K, Khuda Bukhsh AR. Efficacy of a potentized homeopathic drug (Arsenicum-Album-30) in reducing cytotoxic effects produced by arsenic trioxide in mice: IV. Pathological changes, protein profiles, and content of DNA and RNA. Complement Ther Med 2000;8:157-65
75. Datta S, Mallick P, Khuda-Bukhsh AR. Efficacy of a potentized homeopathic drug (Arsenic Album-30) in reducing genotoxic effects produced by arsenic trioxide in mice: II. Comparative efficacy of an antibiotic, actinomycin D alone and in combination with either of two microdoses. Comp Ther Med 1999b;7:156-63
76. Datta S, Biswas SJ, Khuda-Bukhsh AR. Comparative efficacy of pre-, post- and combined pre- and post feeding of two microdoses of a potentized homeopathic drug, Mercurius solubilis, in ameliorating genotoxic effects produced by mercuric chloride in mice. Evid Based Complement Altern Med 2004;1(3):291-00
77. Datta S, Mallick P, Khuda Bukhsh AR. Comparative efficacy of two microdoses of a potentized homeopathic drug, Cadmium Sulphoricum, in reducing cytogenetical effects produced by cadmium chloride in mice: a time- course study. BMC Compl Alter Med 2001;1:9
78. Choudhury H. Cure of cancer in experimental mice with certain biochemic salts. Br Homeopath J 1980;9:168-70
79. Biswas SJ, Khuda-Bukhsh AR. Effect of a homeopathic drug, Chelidonium, in amelioration of p-DAB induced hepatocarcinogenesis in mice. BMC Comp Alt Med 2002;2:1-12
80. Biswas SJ, Pathak S, Bhattacharjee N, et al. Efficacy of a potentized homeopathic drug, Carcinosin-200, fed alone and in combination with another drug, Chelidonium 200, in amelioration of p-DAB induced hepatocarcinogenesis in mice. J Altern Complement Med 2005;11(5):839-54
81. Pathak S, Das JK, Biswas SJ, et al. Protective potentials of a potentized homeopathic drug, Lycopodium-30, in ameliorating azo dye induced hepatocarcinogenesis in mice. Mol Cell Biochem 2006;285:121-31
82. Gebhardt R. Antioxidative, antiproliferative and biochemical effects in HepG2 cells of a homeopathic remedy and its constituent plant tinctures tested separately or in combination. Arzneimittelforschung 2003;53(12):823-30
83. Pathak S, Bhattacharjee N, Das JK, et al. Supportive evidences for anti-cancerous potential of an alternative medicine in hepatocarcinogenesis of mice. Forsch Komplementarmed 2007;14:148-56
84. Bellavite P, Ortolani R, Pontarollo F, et al. Immunology and homeopathy. 4. Clinical studies- Part 1. Evid Based Complement Alternat Med 2006;3(3):293-01
85. Bellavite P, Ortolani R, Pontarollo F, et al. Immunology and homeopathy. 4. Clinical studies- Part 2. Evid Based Complement Alternat Med 2006;3(4):397-09
86. Pathak S, Multani AS, Banerji P, et al. Ruta 6 selectively induces cell death in brain cancer cells but proliferation in normal peripheral blood lymphocytes: a novel treatment for human brain cancer. Int J Oncol 2003;23:975-82
87. Walach H, Sherr J, Schneider R, et al. Homeopathic proving symptoms: result of a local, non-local or placebo process? A blinded, placebo-controlled pilot study. Homeopathy 2004;93:179-85
88. Lewith GT, Brien S, Hyland ME. Presentiment or entanglement? An alternative explanation for apparent entanglement in provings. Homeopathy 2005;94(2):92-5
89. Hyland ME. Extended network generalized entanglement theory: therapeutic mechanisms and empirical predictions. J Altern Complement Med 2003;9:919-36
90. Hyland ME. A brief guide to extended network entanglement theory. Forsch Komplementarmed 2003;10:201-06
91. Milgrom LR. Conspicuous by its absence: the Memory of Water, macro-entanglement, and the possibility of homeopathy. Homeopathy 2007;96:209-19
92. Spence SD, Thompson EA, Barton SJ. Homeopathic treatment for chronic disease: A 6-Year, University-Hospital Outpatient Observational Study. J Altern Complement Med 2005;11(5):793-8
93. Ricotti V, Delanty N. Use of complementary and alternative medicine in epilepsy. Curr Neurol Neurosci Rep 2006;6(4):347-53
94. Simpson CA. Complementary medicine in chronic pain treatment. Phys Med Rehabil Clin N Am 2006;17(2):451-72
95. Molassiotis A, Fernadez-Ortega P, Pud D, et al. Use of complementary and alternative medicine in cancer patients: a European survey. Ann Oncol 2005a;16(4):655-63
96. Balzarini A, Felisi E, Marini A, et al. Efficacy of homeopathic treatment of skin reactions during radiotherapy for breast cancer: a randomized, double blind clinical trial. Br Homeopath J 2000;89:8-12
97. Richardson MA, Straus SE. Complementary and alternative medicine: opportunities and challenges for cancer management and research. Semin Oncol 2002;29:531-45
98. Shen J, Anderson R, Albert PS. Use of complementary and alternative therapies by women with advanced stage breast cancer. BMC Complement Altern Med 2002;2:8-15
99. Chrystal K, Allan S, Forgeson G, et al. The use of complementary and alternative medicine by cancer patients in New Zealand and regional cancer treatment center. N Z Med J 2003;116:1-8
100. Molassiotis A, Fernandez-Ortega P, Pud D, et al. Complementary and alternative medicine use in colorectal cancer patients in seven European countries. Complement Ther Med 2005b;13(4):251-7
101. Molassiotis A, Panteli V, Patiraki E, et al. Complementary and alternative medicine use in lung cancer patients in eight European countries. Complement Ther Clin Pract 2006;12(1):34-9
102. Hana G, Bar-Sela G, Zhana D, et al. The use of complementary and alternative therapies by cancer patients in northern Israel. Isr Med Assoc J 2005;7(4):243-7
103. Biswas SJ, Bhattacharjee N, Khuda-Bukhsh AR. Efficacy of a plant extract (Chelidonium majus L.) in combating induced hepatocarcinogenesis in mice. Food Chem Toxicol 2008;46;1474-87
104. Belon P, Banerjee A, Roy Karmakar S, et al. Homeopathic remedy for arsenic toxicity?: Evidence-based findings from a randomized placebo controlled double blind human trial. Sci Total Environ 2007;384:141-50
105. Banerjee A, Basu Chakrabarty S, Roy Karmakar S, et al. Can homeopathy bring additional benefits to thalassemic patients on hydroxyurea therapy? Encouraging results of a preliminary study. Evid Based Complement Alternat Med 2007:doi:10.1093/ecam/nem161
106. Banerjee P, Biswas SJ, Belon P, et al. A potentized homeopathic drug, Arsenicum Album 200, can ameliorate genotoxicity induced by repeated injections of arsenic trioxide in mice. J Vet Med A Physiol Pathol Clin Med 2007;54(7):370-6
107. Banerjee P, Bhattacharjee SS, Pathak S, et al. Comparative efficacies of microdoses of a potentized homeopathic drug, Arsenicum Album in amelioration of toxicity induced by repeated sub-lethal injections of Arsenic trioxide in mice. Pathobiology 2007;75(3):doi:10.1159/000 XXXXXX.
108. Bhattacharjee N, Pathak S, Khuda-Bukhsh AR. Amelioration of carcinogen induced toxicity in mice by administration of a potentized homeopathic drug, natrum sulphuricum 200. Evid Based Complement Alternat Med 2007:1-11; doi:10.1093/ecam/nem067
109. Belon P, Banerjee P, Chaki Choudhury S, et al. Can administration of potentized homeopathic remedy, Arsenicum Album, alter anti-nuclear antibody (ANA) titer in people living in high risk arsenic contaminated areas?:I.A correlation with certain hematological parameters. Evid Based Complement Alternat Med 2006;3(1):99-07
110. Khuda-Bukhsh AR, Pathak S, Guha B, et al. Can homeopathic arsenic remedy combat arsenic poisoning in human exposed to groundwater arsenic contamination? a preliminary report on first human trial. Evid Based Complement Alternat Med 2005;2(4):537-48
111. Bensoussan M, Jovenin N, Garcia B, et al. Complementary and alternative medicine use by patients with inflammatory bowel disease: results from a postal survey. Gastroenterol Clin Biol 2006;30(1):14-23
112. Chakrabarti J, Biswas SJ, Khuda-Bukhsh AR. Cytogenetical effects of ultrasound in mice and their modulations by Actinomycin D and an unconventional drug. Indian J Exp Biol 2001;39:1235-9
113. Behjat S. International drug regulators discuss homeopathy. Homeopathy 2002;91(4):267
114. WHO drug information, vol 181:27-29, 2004. Available from: http://www.who.int/druginformation
115. Borneman JP, Field RI. Regulation of homeopathic drug products. Am J Health Syst Pharm 2006;63(1):86-91